Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-16-003611
Filing Date
2016-11-08
Accepted
2016-11-08 09:50:58
Documents
70
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg10qaj.htm 10-Q 1388276
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cbmg_ex311.htm EX-31.1 17583
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cbmg_ex321.htm EX-32.1 10428
  Complete submission text file 0001654954-16-003611.txt   3981036

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cmbg-20160930.xml EX-101.INS 538822
5 XBRL TAXONOMY EXTENSION SCHEMA cmbg-20160930.xsd EX-101.SCH 35158
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmbg-20160930_cal.xml EX-101.CAL 56676
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmbg-20160930_def.xml EX-101.DEF 91904
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmbg-20160930_lab.xml EX-101.LAB 262472
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmbg-20160930_pre.xml EX-101.PRE 198972
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 161980197
SIC: 2836 Biological Products, (No Diagnostic Substances)